AgomAb Therapeutics N.V. American Shares
AGMB | NASDAQ
$6.82
-$0.67 (-8.95%)
Nov 2, 2026, 11:25 AM ET · Market open
TTM Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|
Net Income | -35.68M | -30.01M | -11.73M |
Depreciation & Amortization | 24K | 192K | 85K |
Stock-Based Compensation | 2.76M | 1.84M | 499K |
Other Working Capital | 1.5M | -1.5M | -1.62M |
Other Non-Cash Items | 4.59M | 3.4M | 333K |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | 1.5M | -1.5M | -1.62M |
Operating Cash Flow | -26.81M | -26.08M | -12.44M |
Capital Expenditures | -4K | -363K | -363K |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a |
Other Investing Acitivies | -30M | n/a | n/a |
Investing Cash Flow | -30M | -363K | -363K |
Debt Repayment | -190K | -219K | -63K |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -130K | -130K |
Financial Cash Flow | -190K | 81.71M | 81.86M |
Net Cash Flow | -56.96M | 55.07M | 68.86M |
Free Cash Flow | -26.81M | -26.44M | -12.8M |
Adj. Free Cash Flow | -29.57M | -28.28M | -13.3M |
Maintenance CapEx | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a |
Owner Earnings | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AGMB